Andrea Corazza (@andreacorazza) 's Twitter Profile
Andrea Corazza

@andreacorazza

EU advocate, interested in health, international affairs and EU external policies. Tweets are personal. RTs ≠ endorsement.

ID: 48110420

calendar_today17-06-2009 20:50:07

1,1K Tweet

390 Takipçi

875 Takip Edilen

POLITICO Live (@livepolitico) 's Twitter Profile Photo

🌍💉 Join us for a captivating spotlight discussion on "Vaccination in a Post-Pandemic World: Is Europe Ready?" With speakers from the Czech Ministry of Health, and our presenting partner Novavax among others! #POLITICOHealthCare x.com/i/broadcasts/1…

Assurance Maladie (@assur_maladie) 's Twitter Profile Photo

#VaccinGrippeEtCovid19 │"Parce que vous pouvez les croiser n'importe où. #NeChoisissezPas, faites-vous vacciner contre la Grippe ET le Covid-19" 💉💉 @Assur_maladie, Ministère de la Santé et de l'Accès aux soins, SantépubliqueFrance et La MSA lancent une campagne de sensibilisation à la double #Vaccination

EU Medicines Agency (@ema_news) 's Twitter Profile Photo

‼️ EMA has recommended authorising an adapted Nuvaxovid #COVID19vaccine targeting the #Omicron XBB.1.5 subvariant. It will be used for preventing #COVID19 in adults and children from 12 years of age. ➡️ ema.europa.eu/en/news/ema-re… #UnitedInProtection

‼️ EMA has recommended authorising an adapted Nuvaxovid #COVID19vaccine targeting the #Omicron XBB.1.5 subvariant.

It will be used for preventing #COVID19 in adults and children from 12 years of age.

➡️ ema.europa.eu/en/news/ema-re…

#UnitedInProtection
Novavax (@novavax) 's Twitter Profile Photo

Today, the EU Medicines Agency #CHMP recommended for approval our updated protein-based non-mRNA #COVID19 vaccine in the European Union to protect against emerging variants. Learn more: novav.ax/3tTCNY7

Novavax (@novavax) 's Twitter Profile Photo

The European Commission has approved our updated protein-based non-mRNA #COVID19 vaccine in the European Union. Read more about the approval: ir.novavax.com/press-releases…

The <a href="/EU_Commission/">European Commission</a> has approved our updated protein-based non-mRNA #COVID19 vaccine in the European Union.

Read more about the approval: ir.novavax.com/press-releases…
EU One Health (@eu_health) 's Twitter Profile Photo

#COVID19: Following EU Medicines Agency' positive evaluation, we've authorised a 3⃣rd adapted vaccine for use in 🇪🇺 countries' autumn/winter vaccination campaigns. Nuvaxovid XBB.1.5 is the first protein-based adapted vaccine authorised for this autumn & winter season. #UnitedInProtection

Stella Kyriakides (@skyriakideseu) 's Twitter Profile Photo

The #COVID19 variant adapted Nuvaxovid vaccine is now authorised for use following a positive opinion by EU Medicines Agency. It offers another option for all those seeking to increase their protection against COVID this autumn and winter.

Novavax (@novavax) 's Twitter Profile Photo

Our Executive Vice President, Chief Corporate Affairs and Advocacy Officer, Silvia Taylor, attended POLITICO Live's #POLITICOHealthCare Summit alongside industry experts to discuss the importance of vaccine options. Learn more here: politico.eu/healthcare-sum…

Our Executive Vice President, Chief Corporate Affairs and Advocacy Officer, <a href="/SilT2/">Silvia Taylor</a>, attended <a href="/LivePOLITICO/">POLITICO Live</a>'s #POLITICOHealthCare Summit alongside industry experts to discuss the importance of vaccine options. Learn more here: politico.eu/healthcare-sum…
European Business Summits (@ebsummiteurope) 's Twitter Profile Photo

COVID-19 is still a serious health threat, according to Andrea Corazza Novavax 👇 “COVID-19 infections and hospitalisations are on the rise across Europe. Even if the pandemic is over, to keep citizens protected we need to maintain high rates of COVID-19 vaccination.”

COVID-19 is still a serious health threat, according to <a href="/AndreaCorazza/">Andrea Corazza</a> <a href="/Novavax/">Novavax</a> 👇

“COVID-19 infections and hospitalisations are on the rise across Europe. Even if the pandemic is over, to keep citizens protected we need to maintain high rates of COVID-19 vaccination.”
European Business Summits (@ebsummiteurope) 's Twitter Profile Photo

What was the key lesson from the COVID-19 pandemic? “Europe needs a strong research ecosystem, supporting multiple technology platforms. This was a game-changer to address COVID-19, and will be key to developing a vaccine for the next pandemic.” Andrea Corazza Novavax #ehs2023

What was the key lesson from the COVID-19 pandemic?

“Europe needs a strong research ecosystem, supporting multiple technology platforms. This was a game-changer to address COVID-19, and will be key to developing a vaccine for the next pandemic.” 
<a href="/AndreaCorazza/">Andrea Corazza</a> <a href="/Novavax/">Novavax</a> #ehs2023
European Business Summits (@ebsummiteurope) 's Twitter Profile Photo

“The role of vaccines is all the more important in the face of climate change. This is already having an impact, and vaccines are crucial to manage new disease outbreaks and prevent antimicrobial resistance.” Andrea Corazza Novavax #ehs2023

“The role of vaccines is all the more important in the face of climate change. 

This is already having an impact, and vaccines are crucial to manage new disease outbreaks and prevent antimicrobial resistance.” 

<a href="/AndreaCorazza/">Andrea Corazza</a> <a href="/Novavax/">Novavax</a> #ehs2023
EU HERA (@ec_hera) 's Twitter Profile Photo

Thanks to European Business Summits for this great opportunity to debate on #OneHealth and pandemic #preparedness. Broad agreement in particular on the need to support the development of new #antibiotics, a strong priority of HERA. Sara Cerdas @saracerdas.bsky.social Andrea Corazza josep figueras

Neil Betteridge (@neil_betteridge) 's Twitter Profile Photo

Published today - White Paper from the European Alliance for Patient Access on equitable access to #Vaccinations tinyurl.com/2dtm9n3d

Published today - White Paper from the European Alliance for Patient Access on equitable access to #Vaccinations 

tinyurl.com/2dtm9n3d
University of Oxford (@uniofoxford) 's Twitter Profile Photo

One to watch: The Battle to Beat Malaria 🦟 📺 BBC Two 🕗 Tonight at 8pm (BST) Watch the inside story of how scientists from Oxford developed a new Malaria vaccine. More info ➡️ bbc.co.uk/programmes/m00…

Novavax (@novavax) 's Twitter Profile Photo

Novavax has received Emergency Use Authorization from the U.S. #FDA for its updated COVID-19 vaccine in individuals aged 12 and older. Pre-filled syringes are expected to be available in thousands of locations across the U.S. in the coming days. Read the press release:

Montgomery County, MD - County Exec Marc Elrich (@montcoexec) 's Twitter Profile Photo

Starting off the day with a local shot! Thank you Councilmember Kristin Mink for bringing us together this morning with our partners at Giant Food and local vaccine manufacturer Novavax to promote getting the updated COVID vaccine.

Starting off the day with a local shot! Thank you <a href="/CMKristinMink/">Councilmember Kristin Mink</a> for bringing us together this morning with our partners at <a href="/GiantFood/">Giant Food</a> and local vaccine manufacturer <a href="/Novavax/">Novavax</a> to promote getting the updated COVID vaccine.
Councilmember Kristin Mink (@cmkristinmink) 's Twitter Profile Photo

Just got a Novavax COVID💉with County & state officials & community partners to spread the word about availability & importance of ’24-25 COVID vax! All brands are good, but Novavax is MoCo-based✨ Thanks Giant Food for hosting & Montgomery County, MD - County Exec Marc Elrich + many more for getting vaxed w/ me!

Just got a <a href="/Novavax/">Novavax</a> COVID💉with County &amp; state officials &amp; community partners to spread the word about availability &amp; importance of ’24-25 COVID vax! All brands are good, but Novavax is MoCo-based✨

Thanks <a href="/GiantFood/">Giant Food</a> for hosting &amp; <a href="/MontCoExec/">Montgomery County, MD - County Exec Marc Elrich</a> + many more for getting vaxed w/ me!
Novavax (@novavax) 's Twitter Profile Photo

The @European Commission has granted authorization for our updated #COVID19 vaccine in individuals aged 12 and older in the European Union to protect against currently circulating variants. Read the press release: novav.ax/47X5IKL